La larga espera por la cura de la diabetes

Un documental recoge la desesperación y la frustración de los pacientes de diabetes de tipo 1 que participan en un ensayo clínico.

Dr. Joseph Mercola: The Misinformation ‘Superspreader’

A new documentary from The New York Times explores the contentious career and business of the Florida-based physician.

The Inflation Reduction Act Is a Huge Health Care Reform

America is determining the shape of health care affordability into the future.

Hospital and Drugmaker Move to Build Vast Database of New Yorkers’ DNA

Patients will be asked if their genetic sequence can be added to a database — shared with a pharmaceutical company — in a quest to cure a multitude of diseases.

House Approves Climate, Tax and Health Care Legislation

House Democrats overcame Republican opposition to pass legislation that would cut prescription drug costs and invest billions in efforts to combat global warming.

Johnson & Johnson Will Discontinue Talc-Based Baby Powder Globally in 2023

The company, sued by cancer patients who claimed its talc was contaminated with asbestos, stopped using the ingredient in North America in 2020.

Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Says

Testing found nitrosamine contamination in some samples of Januvia, but regulators will allow Merck to continue selling the drug for now.

Medicare Recipients Could Find Drug Cost Relief in Health Bill

Starting in 2025, Medicare recipients with prescription drug coverage will not have to pay more than $2,000 annually for medications, a significant savings for some.

How Democrats Salvaged a History-Making Bill

The climate change and prescription drug law has revived a set of party goals that were widely thought to be dead.

Overlooked Provisions

Climate has received most of the attention. But the Senate bill brings big changes to health care, too.